Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMBIM4 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KMT2D - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
PIGP - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
NEDD4L - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GOLPH3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
EPB41L4B - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
HNRNPK - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
MSL1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LRRC41 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CTSO - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
NFIA - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
RAB11A - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
RNF145 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
C12orf4 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CDC42SE1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
TOR1A - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CD9 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on